research

Mayo Clinic researchers may have discovered a genomic signature to predict which people with mesothelioma could benefit from immunotherapy.  

The American Society of Hematology (ASH) recognized Mayo Clinic hematologist Stephen Ansell, M.D., with the highly distinguished Ernest Beutler Lecture and Prize in recognition of his significant contributions to the field of lymphoma research.

Mayo Clinic researchers have found that a new, shorter treatment for patients with HPV-associated oropharynx cancer leads to excellent disease control and fewer side effects, compared to standard treatment.

The antipsychotic medication olanzapine might help patients with advanced cancer successfully manage nausea and vomiting unrelated to chemotherapy, according to Mayo Clinic researchers who published[...]

The density of tumor-infiltrating lymphocytes when combined with an analysis of tumor budding may serve as a method to more accurately predict survival in patients[...]

Researchers from Mayo Clinic Cancer Center who co-led a clinical trial of a new blood test designed to detect more than 50 types of cancer[...]

A study by Mayo Clinic researchers published in the journal Scientific Reports has identified a microbiome signature associated with endometrial cancer, which is in part[...]

Native American patients with cancer tend to have significant concerns about radiation therapy that are not being addressed adequately, according to a collaborative study by[...]

The best is yet to come. It's been 14 years since I arrived in Rochester, Minnesota, to lead Mayo Clinic Cancer Center, and the time[...]

Research from Mayo Clinic investigators presented at the 2019 San Antonio Breast Cancer Symposium suggests that some women with an elevated risk of developing breast[...]